Ahmed Basudan
Overview
Explore the profile of Ahmed Basudan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Elangovan A, Bossart E, Basudan A, Tasdemir N, Shah O, Ding K, et al.
bioRxiv
. 2023 Sep;
PMID: 37745587
Financial Support: The work was in part supported by a Susan G Komen Leadership Grant to SO (SAC160073) and NCI R01 CA252378 (SO/AVL). AVL and SO are Komen Scholars, Hillman...
2.
Alfhili M, Alsughayyir J, Basudan A, Alfaifi M, Awan Z, Algethami M, et al.
Saudi J Biol Sci
. 2023 Feb;
30(3):103577.
PMID: 36816730
Polyunsaturated fatty acids (PUFAs) may favorably influence the risk and clinical course of diabetes mellitus (DM). In particular, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and arachidonic acid (AA) alleviate oxidative...
3.
Alfhili M, Alsughayyir J, Basudan A, Ghneim H, Aboul-Soud M, Marie M, et al.
Medicina (Kaunas)
. 2022 Aug;
58(8).
PMID: 36013507
Inflammation is pivotal to the pathogenesis of diabetes mellitus (DM), but pathological alterations of the neutrophil−lymphocyte ratio (NLR), an emerging inflammatory index in DM management, remains understudied. The aim of...
4.
Alghamdi M, Alhumsi T, Altweijri I, Alkhamis W, Barasain O, Cardona-Londono K, et al.
Front Pediatr
. 2021 May;
9:582816.
PMID: 33937142
Craniosynostosis (CS) is defined as pre-mature fusion of one or more of the cranial sutures. CS is classified surgically as either simple or complex based on the number of cranial...
5.
Sreekumar S, Levine K, Sikora M, Chen J, Tasdemir N, Carter D, et al.
Endocrinology
. 2020 Jul;
161(9).
PMID: 32609836
Invasive lobular breast carcinoma (ILC) accounts for 10% to 15% of breast cancers diagnosed annually. Evidence suggests that some aspects of endocrine treatment response might differ between invasive ductal carcinoma...
6.
Levine K, Priedigkeit N, Basudan A, Tasdemir N, Sikora M, Sokol E, et al.
NPJ Breast Cancer
. 2019 Jul;
5:19.
PMID: 31263748
Invasive lobular carcinoma (ILC) is an understudied subtype of breast cancer that requires novel therapies in the advanced setting. To study acquired resistance to endocrine therapy in ILC, we have...
7.
Cao L, Basudan A, Sikora M, Bahreini A, Tasdemir N, Levine K, et al.
Cancer Lett
. 2019 Jun;
461:21-30.
PMID: 31229512
Invasive lobular carcinoma (ILC) is the second most common histological subtype of breast cancer following invasive ductal carcinoma (IDC). To identify potential genetic drivers of ILC progression, we used NanoString...
8.
Bossart E, Tasdemir N, Sikora M, Bahreini A, Levine K, Chen J, et al.
Breast Cancer Res Treat
. 2019 Feb;
175(2):327-337.
PMID: 30798422
Purpose: Invasive lobular carcinoma (ILC) is a histological subtype of breast cancer that is predominantly estrogen receptor alpha (ER)-positive (+) and is thus treated with endocrine therapies. Herein, we sought...
9.
Basudan A, Priedigkeit N, Hartmaier R, Sokol E, Bahreini A, Watters R, et al.
Mol Cancer Res
. 2018 Oct;
17(2):457-468.
PMID: 30355675
DNA sequencing has identified a limited number of driver mutations in metastatic breast cancer beyond single base-pair mutations in the estrogen receptor (). However, our previous studies and others have...
10.
Vareslija D, Priedigkeit N, Fagan A, Purcell S, Cosgrove N, OHalloran P, et al.
J Natl Cancer Inst
. 2018 Jul;
111(4):388-398.
PMID: 29961873
Background: Breast cancer brain metastases (BrMs) are defined by complex adaptations to both adjuvant treatment regimens and the brain microenvironment. Consequences of these alterations remain poorly understood, as does their...